Primary Amyloidosis Clinical Trials

Find Primary Amyloidosis Clinical Trials Near You

CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The objective of this observational, prospective study is to determine the prevalence of Cardiac Amyloidosis (CA) in males over the age of 65 who experience chest pain but show no signs of coronary artery disease (CAD). Prior to inclusion, all patients will have undergone a CT coronary angiogram or an Rb-PET scan to rule out the possibility of CAD. Participants will be subject to several examinations, including blood tests, urine samples, ECG, echocardiography, and bone scintigraphy. An endomyocardial biopsy may be conducted if necessary.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 65
Healthy Volunteers: f
View:

• No signs of CAD through Rb-PET and/or CT coronary arteriogram

Locations
Other Locations
Denmark
Rigshospitalet
RECRUITING
Copenhagen
Contact Information
Primary
Navid Noory, MD
navid.noory@regionh.dk
4535453108
Time Frame
Start Date: 2024-04-01
Estimated Completion Date: 2027-04-01
Participants
Target number of participants: 300
Treatments
Other: Interventional group
Sponsors
Leads: Rigshospitalet, Denmark

This content was sourced from clinicaltrials.gov